Timo Gaiser
Impact in
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Surgical Treatments
- Cancer Cells and Metastasis
-
- Gastric Cancer Management and Outcomes
Papers in
- Oncology 47
- HER2/EGFR in Cancer Research 11
- Colorectal Cancer Treatments and Studies 8
- Cancer Immunotherapy and Biomarkers 7
-
- Gastric Cancer Management and Outcomes 19
- Co-authors
- Alexander Marx (15 shared papers)Jakob Nikolas Kather (9 shared papers)Cleo‐Aron Weis (10 shared papers)Markus David Siegelin (12 shared papers)Antje Habel (9 shared papers)Daniela D. Hirsch (23 shared papers)Susanne Melchers (3 shared papers)Esther Herpel (3 shared papers)
- Journals
- International Journal of Cancer (6 papers)European Journal of Cancer (6 papers)Annals of Oncology (6 papers)Oncotarget (6 papers)Scientific Reports (4 papers)
- Partner nations
- GermanyUnited StatesAustria
In The Last Decade
Timo Gaiser
154 papers receiving 7.5k citations
Timo Gaiser's Hit Papers
Peers
Comparison fields: 5 of 127
- Oncology 1.6k
- Pulmonary and Respiratory Medicine 2k
- Health Informatics 89
- Artificial Intelligence 1.2k
- Cancer Research 415
Countries citing papers authored by Timo Gaiser
This map shows the geographic impact of Timo Gaiser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timo Gaiser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timo Gaiser more than expected).
Fields of papers citing papers by Timo Gaiser
This network shows the impact of papers produced by Timo Gaiser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timo Gaiser. The network helps show where Timo Gaiser may publish in the future.
Co-authors
The 25 scholars most cited alongside Timo Gaiser, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 157 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial Hit paper breakdown → | 2019 | 1880 |
| 2 | Predicting survival from colorectal cancer histology slides using deep learning: A retrospective multicenter study Hit paper breakdown → | 2019 | 785 |
| 3 | Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial Hit paper breakdown → | 2016 | 585 |
| 4 | Multi-class texture analysis in colorectal cancer histology Hit paper breakdown → | 2016 | 423 |
| 5 | 2010 | 260 | |
| 6 | 2021 | 231 | |
| 7 | 2018 | 230 | |
| 8 | 2013 | 144 | |
| 9 | Perioperative Atezolizumab Plus Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel for Resectable Esophagogastric Cancer: Interim Results From the Randomized, Multicenter, Phase II/III DANTE/IKF-s633 Trial Hit paper breakdown → | 2023 | 139 |
| 10 | 2010 | 108 | |
| 11 | 2007 | 102 | |
| 12 | 2012 | 80 | |
| 13 | 2009 | 79 | |
| 14 | 2017 | 78 | |
| 15 | 2009 | 74 | |
| 16 | 2022 | 71 | |
| 17 | 2013 | 70 | |
| 18 | 2021 | 67 | |
| 19 | 2022 | 66 | |
| 20 | 2018 | 59 |
About Timo Gaiser
Timo Gaiser is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine, Cancer Research and Artificial Intelligence, having authored 157 papers that have together received 7.6k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (19 papers), AI in cancer detection (14 papers), HER2/EGFR in Cancer Research (11 papers), Genetic factors in colorectal cancer (9 papers), Lymphoma Diagnosis and Treatment (9 papers), Cancer Genomics and Diagnostics (9 papers), Colorectal Cancer Treatments and Studies (8 papers) and Cancer Immunotherapy and Biomarkers (7 papers). The work is most often cited by research in Oncology (1.6k citations), Pulmonary and Respiratory Medicine (2k citations), Health Informatics (89 citations), Artificial Intelligence (1.2k citations) and Cancer Research (415 citations). Timo Gaiser has collaborated with scholars based in Germany, United States and Austria. Frequent co-authors include Alexander Marx, Jakob Nikolas Kather, Cleo‐Aron Weis, Markus David Siegelin, Antje Habel, Daniela D. Hirsch, Susanne Melchers, Esther Herpel, Hermann Brenner and Niels Halama. Their work appears in journals such as International Journal of Cancer, European Journal of Cancer, Annals of Oncology, Oncotarget and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.